EMA adopts guideline on using pharmacogenetics in evaluating pharmacokinetics of drugs
This article was originally published in SRA
The European Medicines Agency has adopted a guideline on the use of pharmacogenetic methodologies in the pharmacokinetic evaluation of medicinal products1.
You may also be interested in...
The company is looking at deals in the $2bn to $5bn range, CEO Paul Hudson told investors, but premiums for assets are high and Sanofi is looking at earlier-stage opportunities as a result.